CROSSJECT announces initiation of coverage of its stock by Portzamparc (BNP Paribas Group) DIJON, France - February 2, 2026 (7:15 a.m. CET) – CROSSJECT (ISIN: FR0011716265; Euronext: ALCJ), the specialty pharmaceutical company that develops products for emergency situations based on its proprietary ZENEO® needle-free auto-injector technology.
[21/01/2026] Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful. [BETCLIC EVEREST GROUP SAS] Post-stabilisation Period Announcement NO STABILISATION CARRIED OUT [Further to the pre-stabilisation period announcement dated [20/01/2026] BNP Paribas (contact: Stanford Hartman telephone: 0207 595 8222) hereby gi...
Ernest Hoffman is a Crypto and Market Reporter for Kitco News. He has over 15 years of experience as a writer, editor, broadcaster and producer for media, educational and cultural organizations.
[15.01.2026] Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful. [TEREOS FINANCE GROUP I SA] Post-stabilisation Period Announcement NO STABILISATION CARRIED OUT [Further to the pre-stabilisation period announcement dated 14.01.2026 BNP Paribas (contact: Stanford Hartman telephone: 0207 595 8222) hereby give...
SUDAN LITIGATION: RULING CLEARS PATH FOR BNP PARIBAS APPEAL Paris, 8 January 2026 On the 7th of January 2026, the decision by the judge to certify the October verdict clears the path for BNP Paribas to pursue its appeal. BNP Paribas welcomes the Court's decision as it allows the bank to pursue the procedure as planned.
Under the liquidity contract with EUTELSAT COMMUNICATIONS at BNP PARIBAS, at the settlement date of 31 December 2025, the following assets appeared on the liquidity account
BNP Paribas share buyback programme Declaration of transactions in own shares from December 15, 2025 to December 19, 2025 PRESS RELEASE Paris, 22 December 2025 In accordance with Article 5 of Regulation (EU) No 596/2014 on Market Abuse and Article 3 (3) of Delegated Regulation (EU) 2016/1052 supplementing Regulation (EU) No 596/2014 through regulatory technical standards concerning the conditio...
Kostenlos registrieren
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.